Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC), the agency announced on ...

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...